Photo taken from Daniel Stover/X
Sep 9, 2024, 11:46
Association between TIL and survival in patients with MBC receiving first-line chemotherapy
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a paper by Daniel Stover et al. on X, adding:
“Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502.
- To evaluate the association of sTILs with progression-free survival in randomized phase III trial CALGB 40502.
- sTILs were associated with progression-free and overall survival in chemotherapy-treated MBC when controlling for treatment arm; however, this effect did not remain significant after additional adjustment for hormone receptor status.”
Source: Elisabetta Bonzano/X
Authors: Daniel G. Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L. Mayer, Mark Jesus M. Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, W. Fraser Symmans, Charles Perou, Lisa A. Carey, Ann H. Partridge and Hope S. Rugo.
Ann H. Partridge
Breast Cancer
CALGB 40502
cancer
Charles Perou
chemotherapy
Daniel G. Stover
Elisabetta Bonzano
Erica L. Mayer
Hope S. Rugo
Karla Ballman
Kristyn Glover
Lisa A. Carey
Mark Jesus M. Magbanua
Mark Vater
Mark Watson
Oleksander Savenkov
OncoDaily
Oncology
Roberto Salgado
Sherene Loi
W. Fraser Symmans
Yujia Wen
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 10:18
Nov 19, 2024, 10:05
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28